Global Pancreatic and Biliary Stents Market Analysis (2015-2020) and Forecast (2020-2030) Model - Key Trends and Developments Resulting from the COVID-19 Pandemic

DUBLIN, Aug. 13, 2020 /PRNewswire/ -- The "Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to's offering.

This market model is built to visualize quantitative market trends within General Surgery therapeutic area.

The Pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fueled the market especially the procedures requiring stenting and recurrent stenting.

Disorders of the biliary duct effect a major portion of the world and it is increasing every year which is evidenced by increase in the number of ERCP procedures. Biliary obstruction from malignant causes is quite common, with as many 70% of the pancreatic cancer patients presenting with obstruction upon diagnosis. Every year more than 500,000 ERCP procedures including diagnostic as well as surgical, are carried out alone in the United States.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Pancreatic and Biliary stent and evolving competitive landscape.

    --  Insightful review of the key industry trends.
    --  Annualized total Pancreatic and Biliary stent market revenue by segment
        and market outlooks from 2015-2030.
    --  Granular data on total procedures, units, average selling prices and
        market values by segment.

Global, Regional and Country level market specific insights.

    --  Qualitative market specific information is available with global trends
        further broken down into regional trends. In addition the publisher's
        analysts provide unique country specific insights on the market.
    --  SWOT analysis for Pancreatic and Biliary stent market.
    --  Competitive dynamics insights and trends provided for Pancreatic and
        Biliary stent market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

    --  Country specific overview of the healthcare system.
    --  Country specific reimbursement policies.
    --  Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Reasons to Buy

The model will enable you to:

    --  Understand the impact of COVID-19 on Pancreatic and Biliary stent
    --  Develop and design your in-licensing and out-licensing strategies
        through a review of pipeline products and technologies, and by
        identifying the companies with the most robust pipeline.
    --  Develop business strategies by understanding the trends shaping and
        driving Pancreatic and Biliary stent market.
    --  Drive revenues by understanding the key trends, innovative products and
        technologies, market segments, and companies likely to impact the
        Pancreatic and Biliary stent market in the future.
    --  Formulate effective sales and marketing strategies by understanding the
        competitive landscape and by analyzing the company share of market
    --  Identify emerging players with potentially strong product portfolios and
        create effective counter-strategies to gain a competitive advantage.
    --  Track device sales in the global and country-specific Pancreatic and
        Biliary stent market from 2015-2030.
    --  Organize your sales and marketing efforts by identifying the market
        categories and segments that present maximum opportunities for
        consolidations, investments and strategic partnerships.

Companies Mentioned

    --  Boston Scientific Corp
    --  Cook Group Inc
    --  Cardinal Health Inc
    --  Medtronic plc
    --  ConMed Corp
    --  W. L. Gore & Associates Inc
    --  Taewoong Medical Co Ltd
    --  Olympus Corp
    --  Becton Dickinson and Co
    --  Micro-Tech (Nanjing) Co Ltd
    --  ELLA-CS sro
    --  Abbott Laboratories
    --  Endo-Flex GmbH
    --  Hobbs Medical Inc

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets